申请人:Vertex Pharmaceuticals Incorporated
公开号:US20130131107A1
公开(公告)日:2013-05-23
The present invention relates to pharmaceutical compositions comprising a compound of Formulas I and II, optionally in combination with a Compound of Formula III and/or a Compound of Formula IV. The invention also relates to solid forms and to pharmaceutical formulations thereof, and to methods of using such compositions in the treatment of CFTR mediated diseases, particularly cystic fibrosis.
本发明涉及含有I和II式化合物的药物组合物,可选地与III式化合物和/或IV式化合物组合使用。本发明还涉及其固体形式和制药配方,以及使用这种组合物治疗CFTR介导的疾病,特别是囊性纤维化的方法。